Genenta Science SpA ADR
Price & Volume
Stats
See more52W Range | $2.49-$7.28 |
Market Cap | $70M |
Shares Short | 1,284 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.57 |
News
See moreYahoo Finance • 9 days ago
Genenta Showcases Strategic Vision at Premier Biotech Forum in Qatar
Yahoo Finance • last month
Genenta Announces €20 million ($21.9M) Financing To Expand Pipeline As Brain Tumor Trial Is Showing Promising Survival Rates
Yahoo Finance • 2 years ago
Genenta to Present at Upcoming Scientific and Investor Conferences
Yahoo Finance • 2 years ago
The European Commission Grants Orphan Drug Designation to Temferon™ for Treatment of Glioma
About
CEO | Mr. Pierluigi Paracchi |
Address | Via Olgettina No. 58, Milan, MI, Italy, 20132 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 13 |
